Abstract
The latest findings of our laboratory showed that Angelica sinensis polysaccharide( ASP) showed a definite effect in regulating the aging of hematopoietic stem cells. Leukemia is a type of malignant hematopoietic tumor in hematopoietic stem cells. There have been no relevant reports about ASP's effect in regulating the aging of leukemia cells. In this study,human acute myeloid leukemia( AML) KG1α cell lines in logarithmic growth phase were taken as the study object,and were divided into the ASP group, the cytarabine( Ara-C) group,the ASP + Ara-C group and the control group. The groups were respectively treated with different concentration of ASP,Ara-C and ASP + Ara-C for different periods,with the aim to study the effect of ASP combined with Ara-C in regulating the aging of human acute myeloid leukemia KG1α cell lines and its relevant mechanism. The results showed that ASP,Ara-C and ASP + Ara-C could obviously inhibit KG1α cell proliferation in vitro,block the cells in G0/ G1phase. The cells showed the aging morphological feature. The percentage of positive stained aging cells was dramatically increased,and could significantly up-regulate the expression of aging-related proteins P16 and RB,which were more obvious in the ASP + Ara-C group. In conclusion,the aging mechanism of KG1α cell induced by ASP and Ara-C may be related to the regulation of the expression of aging-related proteins,suggesting that the combined administration of ASP and anticancer drugs plays a better role in the treatment of leukemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.